Global Trust Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.7K | Buy |
1,163
+650
| +127% | +$17.3K | 0.01% | 283 |
|
|
2025
Q4 | $12.8K | Hold |
513
| – | – | 0.01% | 334 |
|
|
2025
Q3 | $13.1K | Sell |
513
-4
| -0.8% | -$99 | 0.01% | 381 |
|
|
2025
Q2 | $12.6K | Hold |
517
| – | – | 0.01% | 368 |
|
|
2025
Q1 | $13.1K | Sell |
517
-1,174
| -69% | -$30.7K | 0.01% | 342 |
|
|
2024
Q4 | $44.9K | Sell |
1,691
-1,071
| -39% | -$29.1K | 0.02% | 296 |
|
|
2024
Q3 | $79.9K | Sell |
2,762
-13,310
| -83% | -$388K | 0.03% | 253 |
|
|
2024
Q2 | $450K | Sell |
16,072
-1,845
| -10% | -$50.8K | 0.18% | 107 |
|
|
2024
Q1 | $497K | Sell |
17,917
-13,474
| -43% | -$374K | 0.2% | 96 |
|
|
2023
Q4 | $904K | Sell |
31,391
-10,892
| -26% | -$329K | 0.4% | 64 |
|
|
2023
Q3 | $1.4M | Sell |
42,283
-10,595
| -20% | -$375K | 0.67% | 42 |
|
|
2023
Q2 | $1.94M | Sell |
52,878
-780
| -1% | -$30.4K | 0.87% | 29 |
|
|
2023
Q1 | $2.19M | Sell |
53,658
-1,638
| -3% | -$70.7K | 1.04% | 20 |
|
|
2022
Q4 | $2.83M | Sell |
55,296
-97
| -0.2% | -$4.65K | 1.43% | 17 |
|
|
2022
Q3 | $2.42M | Sell |
55,393
-473
| -0.8% | -$23K | 1.26% | 22 |
|
|
2022
Q2 | $2.93M | Buy |
55,866
+296
| +0.5% | +$15.1K | 1.44% | 18 |
|
|
2022
Q1 | $2.88M | Sell |
55,570
-3,418
| -6% | -$177K | 1.2% | 20 |
|
|
2021
Q4 | $3.48M | Buy |
58,988
+2,776
| +5% | +$138K | 1.37% | 16 |
|
|
2021
Q3 | $2.42M | Buy |
56,212
+4,716
| +9% | +$209K | 1.08% | 22 |
|
|
2021
Q2 | $2.02M | Buy |
51,496
+1,241
| +2% | +$48.3K | 0.96% | 25 |
|
|
2021
Q1 | $1.82M | Sell |
50,255
-1,022
| -2% | -$36.3K | 1% | 24 |
|
|
2020
Q4 | $1.89M | Buy |
51,277
+4,057
| +9% | +$149K | 1.04% | 22 |
|
|
2020
Q3 | $1.63M | Buy |
47,220
+31,223
| +195% | +$1.09M | 1.04% | 24 |
|
|
2020
Q2 | $496K | Buy |
15,997
+429
| +3% | +$14.6K | 0.35% | 75 |
|
|
2020
Q1 | $483K | Buy |
15,568
+2,440
| +19% | +$83.1K | 0.38% | 77 |
|
|
2019
Q4 | $488K | Hold |
13,128
| – | – | 0.29% | 102 |
|
|
2019
Q3 | $448K | Buy |
13,128
+4,951
| +61% | +$180K | 0.3% | 95 |
|
|
2019
Q2 | $68K | Buy |
8,177
+6,345
| +346% | +$252K | 0.05% | 203 |
|
|
2019
Q1 | $74K | Sell |
1,832
-17,392
| -90% | -$697K | 0.05% | 192 |
|
|
2018
Q4 | $796K | Buy |
19,224
+10,589
| +123% | +$440K | 0.71% | 39 |
|
|
2018
Q3 | $361K | Buy |
8,635
+5,018
| +139% | +$193K | 0.25% | 100 |
|
|
2018
Q2 | $125K | Buy |
3,617
+1,127
| +45% | +$38.5K | 0.09% | 157 |
|
|
2018
Q1 | $84K | Buy |
2,490
+3
| +0.1% | +$103 | 0.07% | 172 |
|
|
2017
Q4 | $85K | Buy |
+2,487
| New | +$84.8K | 0.06% | 185 |
|
Other funds holding PFE
VCM
VPM
Global Trust Asset Management's PFE Position: Q1 2026 in Review
Global Trust Asset Management increased its Pfizer (PFE) stake by 127% in Q1 2026, buying an estimated $17.3K and bringing the position to 1,163 shares worth $32.7K. The position accounts for 0.01% of the portfolio, ranked #283.
Global Trust Asset Management first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.48M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Global Trust Asset Management held 1,163 shares of Pfizer worth $32.7K as of Q1 2026.
- Global Trust Asset Management bought 650 Pfizer shares in Q1 2026, an estimated $17.3K.
- Pfizer made up 0.01% of Global Trust Asset Management's portfolio in Q1 2026, its #283 holding.
- Global Trust Asset Management first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
- Global Trust Asset Management's Pfizer position peaked at $3.48M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Global Trust Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.